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Background. Lateral elbow pain is one of the most common musculoskeletal pains associated with the upper limb and has an
estimated population incidence of 1–3%.Methods/Design. This study protocol is for a multisite randomised controlled study and is
designed to evaluate the clinical efficacy of acupuncture in the treatment of chronic (over threemonths’ duration) lateral elbow pain.
Four study sites, in the People’s Republic of China, Hong Kong, Italy, and Australia, will recruit 24 participants each. A total of 96
participants will be randomised to either an acupuncture group or a sham laser control group. The primary outcome measure will
be the Disabilities of Arm, Shoulder, and Hand questionnaire with secondary outcome measures of Pain-Free Grip Strength Test,
Muscle Tension Test, and a pain visual analogue scale.Discussion. Key features for conducting amultisite international acupuncture
randomised clinical trial have been detailed in this protocol.Trial Registration.This trial is registered at Australian andNewZealand
Clinical Trial Registry ACTRN12613001138774 on 11 October, 2013.
1. Introduction
Lateral elbow pain (LEP, frequently but incorrectly termed
lateral epicondylitis or tennis elbow) is one of the most
common musculoskeletal pains associated with the upper
limb and has an estimated population incidence of 1–3% [1].
It is a painful condition that is associated with the degen-
eration in the area of the common extensor tendon of the
forearm. Histopathological findings have shown it to be a
degenerative condition (tendinosis) of the common extensor
tendon, with the extensor carpi radialis brevis tendon more
commonly implicated as the primary location of tendinosis.
The anatomic basis of the injury to the extensor carpi
radialis brevis origin appears to be multifaceted, involving
hypovascular zones, eccentric tendon stresses, and a micro-
scopic degenerative response [2].
Optimum treatment of LEP is still debated and research
has not been able to determine an optimum treatment
[3]. Acupuncture has become increasingly recognised as
an alternative treatment for pain, including LEP [4]. In a
publication by the United States National Institutes of Health,
it was determined that acupuncture may be useful as an
adjunct treatment or an acceptable alternative treatment for
tennis elbow (lateral elbow tendinosis) [5]. In the past 15
years, acupuncture has become increasingly recognised as an
alternative treatment for pain, including pain from lateral
elbow tendinosis. However, there is inconclusive evidence
that needle acupuncture has a specific action in the treatment
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of this debilitating condition as shown by Gadau et al. in the
latest systematic review on the topic due to lowmethodologi-
cal quality and the small sample sizes of the individual studies
[6]. The result from a nonrandomised controlled pilot study
(𝑛 = 40) from our group suggests that acupuncture may be
helpful in improving function and pain associated with LEP
[7]. In this study, the treatment group (𝑛 = 20) received nine
unilateral acupuncture treatments at LI 10 and LI 11 on the
affected side withmanual needlemanipulationwhile the con-
trol group (𝑛 = 20) received nine sham-laser-acupuncture
at the same acupoints. Measures included (i) disabilities of
the arm, shoulder, and hand (DASH) questionnaire, (ii) pain-
free grip strength (PFGS), and (iii) visual analogue scale
(VAS) for pain. Significant differences for the DASH score,
PFGS, and VAS between treatment and control group were
found after the 8th treatment (𝑝 < 0.05). Only the DASH
scores showed a significant difference between treatment
and control group for all time points when measurements
were taken which appears to be a sensitive and appropriate
primary outcome measure. Results from this pilot study
provided relevant information concerning treatment efficacy,
credibility of control treatment, and sensitivity of different
outcome measures and were subsequently used to develop
this protocol.
Furthermore, there have been few international multisite
randomised controlled acupuncture trials [8]. This protocol
introduces some of the strategies and procedures that have
been developed to standardise and remote monitor across
sites to ensure the specific key procedures are conducted
in accord with the protocol. This randomised clinical trial
is designed to evaluate the efficacy of acupuncture in the
treatment of chronic (over three months’ duration) lateral
elbow pain, with specific attentions to overcome some of the
limitations of previous studies. The specific hypothesis to be
tested in the study is whether acupuncture is more beneficial
in improving physical function and reducing symptoms for
people with chronic lateral elbow pain of over three months’
duration compared to sham laser.
2. Methods and Design
2.1. Trial Location. The study is to be undertaken at four
international sites. These are Changchun University of Chi-
nese Medicine, People’s Republic of China; Hong Kong Bap-
tist University, HongKong SAR; Paracelso Institute, Italy; and
theUniversity of Technology Sydney,Australia.The studywill
be administered at outpatient clinics attached to each insti-
tution. The World Federation of Acupuncture/Moxibustion
Societies (WFAS) will coordinate the trial and will be respon-
sible for convening the face to face meetings.
2.2. Design. It is a prospective trial that is randomised, con-
trolled, participant/outcome assessor and statistician blinded.
It is a multicentre trial with two parallel groups (𝑛 = 24 at
each site, total participants 𝑛 = 96) with a primary endpoint
evaluation at completion of the intervention phase (week 3)
and a follow-up secondary evaluation three weeks later at
week 6. The treatment group will receive traditional Chinese
style acupuncture and the control group will receive inactive
sham laser therapy to the same local acupuncture points as
the treatment group using a modified inactive laser unit.
2.3. Randomisation. Randomisationwill be performedwith a
1 : 1 allocation using a computer generated sequence with the
randomisation software Minim [10]. Minim is a program for
randomising patients to treatment groups in clinical trials by
the method of minimisation, which reduces the differences
between the groups for the variables used in the allocation
process. Stratification during randomisation will be used
based on the participant’s gender, age, and the DASH score
initially recorded on intake form on recruitment into the
study. Allocation concealment will involve a unique three-
digit code number known only to the third party randomiser
and the practitioner (not outcome evaluator or statistician).
2.4. Inclusion/Exclusion Criteria. To be included in the study,
participants should have chronic lateral elbow pain (duration
> 3 months); have unilateral localization of the pain; be
between 18 and 80 years of age.
Participants will be excluded if they have a disease of the
central or peripheral nervous system; have an inflammatory
rheumatic disease; have gout; had an earlier episode of lateral
elbow pain treated surgically; have had acupuncture treat-
ment or physiotherapy for tennis elbow within the previous
three months or acupuncture treatment for any problems
within the previous week or concurrent physiotherapy for
tennis elbow.
Figure 1 shows the flow of participants through the study.
3. Interventions
The acupuncture administered is based on traditional Chi-
nese medicine (TCM) meridian theory. Two preparative
meetings of representatives from our study group had been
held to discuss the study protocol, especially the selection of
acupuncture and control interventions. Taking into account
results of the pilot study, standardisation, and improvement
from some previous methodological limitations, a standard-
ised intervention procedure has been developed for both
the acupuncture treatment and sham laser control groups.
Interventions are not varied for either group; all participants
will receive the same treatment at all sessions for their
group. Only the affected arm is treated. Practitioners are
required to apply a standardised intervention procedure to
participants dependent on the participant’s randomisation
status. Acupoint selection was based on a consensus by all
four recruiting centres following positive outcomes from the
analysis of data generated from a pilot study undertaken
by one of the research groups at Changchun University of
Chinese Medicine [7].
All acupoints are to bemarkedwith a semipermanent ink.
The two acupoints are to be located as described in theWHO
Standard Acupuncture Point Locations in the Western Pacific
Region [11]. The acupoint Large Intestine (LI) 11 (Quchi) is
located on the lateral aspect of the elbow, at the midpoint of
the line connecting Lung 5 (Chizi) with the lateral epicondyle
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Invitation extended to applicants to participate in trial
Estimated sample size (n = 96 subjects)
24 subjects per site
Entry assessment form is used to screen applicants
against eligibility criteria. Suitable applicants are then
invited to attend an interview
Applicants provided with trial information sheet and
trial entry assessment form
Successful participants complete baseline data
collection
Applicants self-excluded if they do
not meet trial entry
assessment form and/or
inclusion criteria
Excluded if they do not complete
consent form





is no longer willing to
be in the trial
Confirmed willingness to continue in trial to week 1
Participant excluded if they do
not move to treatment within 2
weeks
96 subjects randomised
24 subjects randomised at each site using randomisation software (Minim)
Week 1
Week 3
Week 6Complete 3-week follow-up Complete 3-week follow-up
Loss to follow-up or discontinued
program (9 intervention sessions)
Complete 3-week interventionComplete 3-week intervention
program (9 intervention sessions)
Allocated to acupuncture
intervention (n = 48)
Allocated to sham laser control
intervention (n = 48)
Figure 1: Diagram showing flow of participants.
of the humerus. The acupoint LI 10 (Shousanli) is located on
a line connecting LI 5 (Yangxi) (on the posterolateral aspect
of the wrist, at the radial side of the dorsal wrist crease,
distal to the radial styloid process, in the depression of the
anatomical snuffbox) with LI 11 (Quchi), 2 body units (cun)
inferior to the cubital crease on the forearm.The acupoint LI
10 will be located using a piece of elastic divided into 12 equal
proportions to assist accurate proportional measurement
[12].
3.1. Acupuncture. Single-use, stainless steel, presterile fili-
form 0.30mm × 40mm Hua Tuo brand needles will be used
to needle the acupoint sites following cleansing of the skin
with rubbing alcohol.
3.2. Needle Manipulation. The acupoint LI 11 will be needled
first, perpendicular deep insertion up to 1.5 body units (cun),
and then withdrawn to 1 cun depth. Following insertion, the
traditional needle technique of “Wagging the Dragon’s Tail”
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(WDT) will be performed. This involves holding the needle
on distal end of the handle and bending it 45∘ left and then
right with a speed of 1Hz for 2 minutes or to the participant’s
tolerance. Then, the acupoint LI 10 will then be needled
using oblique insertion at 45 degrees angled towards the
elbow and the same needle technique ofWDT applied for the
same period of time (2 minutes) or to the patient’s tolerance.
Whenever the duration of needle manipulation is less than
the required time of 2 minutes (due to patient request to
stop due to excessive pain or sensation), a note will be kept
of the time the technique was applied. Needling sensation
(deqi) will be sought on both acupoints. Muscle twitch will
be recorded on participant’s daily reporting sheet if achieved
on acupoints LI 10 and/or LI 11.
The needles will be retained for a further period of 24
minutes and then the process of needle manipulation will
be repeated at each site and needles will be withdrawn. In
total, the needles will remain in situ for 28 minutes. Nine
acupuncture treatments will be administered over a three-
week period (three treatments per week).
3.3. Online Training Video for Acupuncturists. A video of
the needle technique (needle insertion and the technique
of “Wagging the Dragon’s Tail”) has been uploaded onto
the cloud repository for review by all the needling research
teams. This is to assist in standardising the intervention
needling technique. All practitioners of needling had at least
seven years of clinical experience and were credentialed as
registered or licensed practitioners.
3.4. Control Intervention. The control group will receive
inactive sham laser therapy to the same local acupuncture
points as the treatment group using a modified inactive laser
unit. This was chosen as the control as the inactive device
appears to treat acupuncture points with laser light but is
inert and does not puncture the skin [9]. The laser probe
is rested lightly on the skin and the inactive sham laser will
be applied at the same sites for the same duration and order
as the acupuncture followed by a rest period of 24 minutes
and then a further two minutes of sham radiation to the two
acupoints will be administered. Similar to the acupuncture
intervention, nine laser sessions will be administered over a
three-week period (three treatments per week).
The laser unitwill have the laser diode removed.Although
themodels of themachines will be different between different
sites, the following properties will apply:The sham laser must
have either light or sound to indicate functionality and be
made of stand and probe; when the beam is invisible, it should
be referred to as infrared; participants should be warned
about the “harmfulness” of laser to the eyes; laser should be
held away from their eyes; the trial participants as well as the
practitioner should wear special laser-protection glasses.
3.5. Outcomes. The primary outcome is the Disabilities of
Arm Shoulder and Hand (DASH) questionnaire.This is a 30-
itemquestionnairewith descriptors for each question ranging
between 1 (no difficulty) to 5 (unable) plus two extra modules
for work and sport [13].TheDASHwill be administered prior
to intervention sessions one and nine and during the follow-
up session at week six.
Secondary outcomes measures are as follows:
(1) Pain-FreeGrip Strength Test (PFGS)Metricmeasure-
ment: all four sites will use a hand held dynamometer
(model J00105 JAMAR). A mean of three measures
will be used for analysis.
(2) Muscle Tension Test (MTT) Metric measurement: all
four sites will use the Lafayette manual muscle tester.
A mean of three measures will be used for analysis.
(3) Pain questionnaire-visual analogue scale (VAS): this
is a 100mm line with the descriptors “no pain”
marked at one end of the scale and “excruciating”
at the other. Three assessments will be made by the
participant of the pain at rest, in motion, and during
exertion.
In addition, the Massachusetts Acupuncture Sensation
Scale (MASS) De Qi Questionnaire [14] which is a self-
report 17-item questionnaire that uses a Likert scale will be
administered twice following intervention sessions one and
nine to measure needling sensation for both the acupuncture
and sham laser groups.
All forms including outcome measure instruments
(DASH, MASS, VAS, PFGS, and MTT) as well as all
CRFs were translated into Chinese language by one of
the researchers (WHL) and checked by two other fluent
English/Chinese members of the research team (MG and
ZSP) for use in Hong Kong and China.
All outcomemeasures will be assessed at baseline, week 3
(following completion of all nine intervention sessions), and
at the follow-up session in week 9. The DASH questionnaire,
PFGS, MTT, and VAS will be administered before the
intervention session commences while the MASS will be
completed following the intervention session.
3.6. Intervention Credibility I and II and Treatment Satis-
faction Questionnaires. In addition, intervention credibility
questionnaires (I at commencement and II at completion
of the intervention phase) are to be administered to all
subjects to assess levels of satisfaction with their allocated
treatment. Questionnaire I asks “how confident are you
that this treatment can alleviate your complaint?” and “how
logical does this treatment seem to you?” [15]. A seven-
point Likert scale (0–6) is to be used with each end point
labelled “not confident” and “confident” to the first question
and “not logical” and “logical” to the second question. This
questionnaire is to be administered after allocation to an
intervention group and prior to receiving their first treatment
of acupuncture or sham laser. Questionnaire II askes “how
confident would you be in recommending this treatment
to a friend who suffered the same complaint?” and “how
successful do you think this treatment would be in alleviating
other complaints?” Similar to the intervention credibility
questionnaire, a seven-point Likert scale (0–6) will be used
with end point labelled “not confident” and “confident” to
the first question and “not successful” and “successful” to
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Figure 2: Schedule of enrolment, interventions, and outcome measures.
the second question.This questionnaire is to be administered
following the participants last intervention.
At the completion of the trial, a Treatment Satisfaction
Questionnairewill also be administered. It includes two ques-
tions: “Do you believe you received a valuable therapeutic
treatment for your lateral elbow pain?” (“yes,” “no,” or “do
not know”) and “what are your reasons for believing this?”
Figure 2 shows the schedule of enrolment, interventions,
and outcome measures.
3.7. Trial Registration. The trial was registered at the Aus-
tralian and New Zealand Clinical Trial Registry at http://
www.ANZCTR.org.au/ACTRN12613001138774.aspx on the
11th October, 2013, following approval from each of the four
institution’s ethical approval committees (commonly referred
to as Independent Research Boards) at all four sites.
3.8. Funding and Ethics Approval. It was agreed that each
site will fund its own costs independently and seek human
research ethics clearance from their regional human research
ethics committee.
3.9. Strategies to Improve Participant Adherence. Upon suc-
cessful admission to the trial, participantswill be given a diary
whichmonitors activities and adherence to the study criteria.
Participants will be instructed on how to use the diary and an
explanation for its use at their initial interview.
3.10. Site Monitoring. Each site will digitally video record
specific segments of trial processes which will then be
uploaded to a secure internet repository for checking against
an agreed checklist by clinical trial personnel at the three
other sites. The checklist to be used for checking each item
of a procedure is shown as follows. A Daily Intervention
Reporting Form is to be used to monitor any comments
or changes reported by participants. An Adverse Reaction
Report Form will be used to record and monitor any adverse
events to the interventions and an Incident Report Sheet has
been developed to record any injury or incident which affects
any person participating in the trail which was not a reaction
to the prescribed interventions.
The nine items and their subelements of the video
monitor checklist are as follows:
(1) Recruitment guidelines
Use of information sheet
Meeting recruitment numbers
(2) Interview
Recruitment officer being familiar with the trial
protocol and able to answer applicant’s ques-
tions appropriately
Trial entry assessment form completed fully
Enrolled applicants meeting eligibility criteria
6 Evidence-Based Complementary and Alternative Medicine
Consent forms completed
Consent forms stored appropriately and sepa-
rated to participant’s folder
(3) Randomisation
Randomisation officer using MINIM software
correctly
Randomisation officer stratifying as per alloca-
tion and randomisation protocol
(4) Baseline and ongoing data collection
Participant deidentified folders and documen-
tation developed and stored securely
Assessor using correct procedures in regard to
scheduling of appointments, interventions, and
assessments in accord with the protocol
Assessor being familiar with questionnaires and
their administration
Assessor being familiar, reliable, and consistent
with physical testing equipment
Competence and consistent in recording test
outcomes on appropriate CRFs
(5) Intervention
Ensuring that practitioners be able to adequately
measure and mark up acupoints on the partici-
pant for treatment in accord with protocol
Participant positioned appropriately
Practitioners having been trained and each
intervention (acupuncture and laser) being
delivered correctly
Practitioners knowing the protocol for any
adverse reactions and/or how to report an inci-
dent
(6) Data collection
Folders being complete with all deidentified files
Participant folders stored in a secure place
(7) Data entry
All CRFs having been collected
Data entry personnel being competent in how
to code CRFs for data entry
Security of both completed paper forms and
electronic spread sheets, including logon and
link password protection to ensure no data
tampering
Software virus scanning
Random data checking (audit) to ensure that
data has been entered correctly
Regular back-up of database
(8) Participant retention and follow-up
Participants having attended all treatments and
if not, the recruitment officer has followed up
(9) Meet and interview
Trial coordinator of site and at least one clini-
cian, trial personnel, or coordinator
(i) Observing at least two participants being
treated
(ii) Verifing that all adverse events have been
documented and recorded on the correct
forms
3.11. Trial and Data Management. All trial documents
including case report forms, outcome measures, the trial
protocol, digital video clips required for trial monitoring,
and the final data excel spreadsheets will be uploaded into
a secure digital cloud repository site which will be managed
by the Hong Kong trial personnel. Regular teleconferences
involving all sites will be undertaken on a regular basis and
conducted in both English and Chinese language. Minutes of
the teleconference meetings will be published and uploaded
into the digital cloud repository site.
3.12. Statistical Evaluation. The statistician will be blind to
allocation status and a variety of statistical tests including
descriptive and inferential tests (ANOVA, chi square) will be
used. A blind third party at theHongKong site will undertake
the statistical analysis following dual data entry, data check-
ing, and revision. Sample size (𝑛 = 96, 24 subjects for each
site) was based on the China pilot study data associated with
the primary outcome, the DASH questionnaire [7] (Liu et al.,
2016).
3.13. Protocol Preparation. The initial trial protocol was
developed in English by theAustralian clinical trial personnel
following consensus by all trial sites. The protocol was
jointly translated by the Australian and Hong Kong clinical
trial personnel into Chinese for use by the Hong Kong
and Changchun trial sites. This protocol has been prepared
in accordance with the SPIRIT (Standard Protocol Items:
Recommendations for Interventional Trials) 2013 [16] and
also conforms to the requirements of the Revised STandards
for Reporting Interventions in Clinical Trials of Acupuncture
(STRICTA) 2010 [17] (see Table 1).
3.14. Current Status. Each site has completed data collection
anddouble entry data sheets have been uploaded to the digital
repository for analysis which has been conducted.
4. Discussion
This is the first time to our knowledge that a protocol for a
multisite international acupuncture randomised clinical trial
has been developed in English. There were many challenges
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Table 1: Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) 2010 items and their description in the
protocol for the treatment group.
Item Detail Description of item
(1) Acupuncture rationale
(1a) Style of acupuncture (e.g., Traditional Chinese
medicine, Japanese, Korean, Western medical, Five
Element, ear acupuncture, etc.)
Traditional Chinese medicine
(1b) Reasoning for treatment provided, based on
historical context, literature sources, and/or consensus
methods, with references where appropriate
Consensus by all four recruiting centres following
positive outcomes from the analysis of data
collected from a pilot study
(1c) Extent to which treatment was varied Not varied except manipulation time shortenedwhen patient by patient
(2) Details of needling
(2a) Number of needle insertions per subject per
session (mean and range where relevant)
Two filiform needle insertions per subject used
per session
(2b) Names (or location if no standard name) of points
used (uni/bilateral)
Large Intestine 11 (Quchi), unilateral
Large Intestine 10 (Shousanli) unilaterally
(2c) Depth of insertion, based on a specified unit of
measurement or on a particular tissue level Needling up to 1.5 body units (cun)
(2d) Response sought (e.g., de qi or muscle twitch
response)
Deqi measured after intervention sessions 1 and 9
using MASS
(2e) Needle stimulation (e.g., manual, electrical) Manual needle stimulation standardised: Waggingthe Dragon’s Tail
(2f) Needle retention time Needles retained 28 minutes
(2g) Needle type (diameter, length, and manufacturer
or material)
Single use, presterile, filiform needles 0.30mm ×
40mm Hua Tuo brand needles (Suzhou Needle
Company)
(3) Treatment regimen (3a) Number of treatment sessions Nine sessions
(3b) Frequency and duration of treatment sessions Three treatments per week
(4) Other components of
treatment
(4a) Details of other interventions administered to the
acupuncture group (e.g., moxibustion, cupping, herbs,
exercises, and lifestyle advice)
No additional interventions administered
Medication use logged in diary if used
(4b) Setting and context of treatment, including
instructions to practitioners, and information and
explanations to patients
Four sites in China, Changchun University of
Chinese Medicine hospital clinic; Hong Kong,
Hong Kong Baptist University clinic; Italy (Center
on Nonconventional Medicine clinic); and
Australia (UTS TCM Clinic)
(5) Practitioner
background
(5) Description of participating acupuncturists
(qualification or professional affiliation, years in
acupuncture practice, other relevant experience)
All practitioners had at least seven years of clinical
experience and were members of the World
Federation of Acupuncture-Moxibustion Societies
(WFAS).
(6) Control or comparator
interventions
(6a) Rationale for the control or comparator in the
context of the research question, with sources that
justify this choice
Noninvasive inactive sham laser which does not
pierce the skin See [9] for justification
(6b) Precise description of the control or comparator. If
sham acupuncture or any other type of
acupuncture-like control is used, provide details as for
items 1 to 3 above.
Inactive sham laser therapy to the same local
acupuncture points as the treatment group using a
modified inactive laser unit
in designing the study, developing the protocol, and opera-
tionalizing the trial. Issues such as language and communi-
cation, achieving protocol consensus, trilingual case report
forms and outcome measures, trial monitoring, individual
site funding, and ethical approval processes needed to be
overcome.
As an international study in different countries with
different cultures, one of the first issues was finding a
common language. Because several researchers at two sites
were bilingual, with English being a common language,
the two main languages used for communication and CRF
development were English and Chinese. However, because
enrolled subjects in each of the countries would not be
bilingual, all documents including the protocol, CRFs, and
outcome measures had to be developed in the English
language and translated into Chinese (for Hong Kong and
Chinese subjects) and Italian (Italian subjects) language.
Achieving consensus for the protocol and the interven-
tion also required careful reflection and planning. Several
face to facemeetings were held prior to designing the study to
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develop the protocol and define the interventions. One of the
research partners from the Changchun University of Chinese
Medicine (WFC) had had extensive experience in treating
lateral elbow pain and suggested a simple acupuncture
technique consisting of two local acupoints (Large Intestine
10 and Large Intestine 11) and a specific needle technique
(Wagging the Dragon’s Tail). The research partners decided
that a pilot study would be necessary to ensure that the
technique was efficient and asked the Chinese research group
to conduct a pilot study before incorporating the acupuncture
technique [7].
Another unique aspect to the protocol was site moni-
toring. Due to the international location of the four sites, a
remote monitoring procedure was developed. This involved
developing a checklist of items to ensure the trial was being
conducted correctly (as per protocol) and in a standardised
manner. The monitoring checklist consisted of several cat-
egories each assessing a different aspect of the trial. These
categories were recruitment guidelines (2 items); interviews
(5 items); randomisation (2 items); baseline and ongoing data
collection (5 items); interventions (4 items); data collection
(2 items); data entry (6 items); and participant retention and
follow-up (1 item).
Each research site is required to make short digital video
clips of segments of the study procedures and upload them
into the digital cloud to a secure repository for viewing and
assessment by the research partners. Each site can then make
an assessment of each item as being present or absent and is
able to provide feedback to each study group so that revision
can be made, if necessary.
Another consideration was funding. Given the different
resources and capabilities at each site, it was decided at
the onset that each site should be responsible for funding
and the supply of both human and physical resources for
their component of the trial. Finally, human research ethics
approval was sought at each individual site using the standard
CRFs and a common consent and information sheet. Special
attention was given to the wording used for the sham laser
control in the consent form; prior to applying for ethics
approval, each site agreed to keep certain clauses similar in
the consent form such as “I understand that the purpose
of this study is to identify if there are any health benefits
using acupuncture or laser for people with lateral elbow
pain” and “Due to the design of the study I will not receive
any information on the specific goals of the interventions.”
This second clause was to address the issue of full informed
consent as the subjects were not aware that a sham laser is
to be administered. If they were fully informed as to this
fact, there is a strong likelihood they may become aware
they are to receive a placebo sham laser treatment. The
argument for not fully informing participants was based on
the lack of a gold standard for treatment of LEP and was
that withholding other treatments will not be detrimental
to the time course or progression of the condition. Human
ethical approval was sought and obtained for all sites in each
jurisdiction.
It is anticipated that the trial results are to be published in
early 2017.
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